# Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

> **NCT04271163** · PHASE1,PHASE2 · UNKNOWN · sponsor: **NeuroEM Therapeutics, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DEVICE:** MemorEM

## Key facts

- **NCT ID:** NCT04271163
- **Lead sponsor:** NeuroEM Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-10
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-03-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04271163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04271163, "Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04271163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*